SGIOY Shionogi & Co Ltd ADR

USD 12.74 -0.05 -0.39093
Icon

Shionogi & Co Ltd ADR (SGIOY) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 12.74

-0.05 (-0.39)%

USD 15.48B

0.05M

N/A

N/A

Icon

SGIOY

Shionogi & Co Ltd ADR (USD)
COMMON STOCK | OTC
USD 12.74
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 15.48B

N/A

USD 12.74

Shionogi & Co Ltd ADR (SGIOY) Stock Forecast

N/A

Based on the Shionogi & Co Ltd ADR stock forecast from 0 analysts, the average analyst target price for Shionogi & Co Ltd ADR is not available over the next 12 months. Shionogi & Co Ltd ADR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Shionogi & Co Ltd ADR is Neutral, which is based on 8 positive signals and 7 negative signals. At the last closing, Shionogi & Co Ltd ADR’s stock price was USD 12.74. Shionogi & Co Ltd ADR’s stock price has changed by -1.47% over the past week, +4.68% over the past month and +12.84% over the last year.

No recent analyst target price found for Shionogi & Co Ltd ADR
No recent average analyst rating found for Shionogi & Co Ltd ADR

Company Overview Shionogi & Co Ltd ADR

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-...Read More

https://www.shionogi.com

1-8, Doshomachi 3-chome, Osaka, Japan, 541-0045

5,680

March

USD

USA

Adjusted Closing Price for Shionogi & Co Ltd ADR (SGIOY)

Loading...

Unadjusted Closing Price for Shionogi & Co Ltd ADR (SGIOY)

Loading...

Share Trading Volume for Shionogi & Co Ltd ADR Shares

Loading...

Compare Performance of Shionogi & Co Ltd ADR Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SGIOY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Shionogi & Co Ltd ADR (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
MKGAF
MERCK Kommanditgesellschaft au.. +2.59 (+1.48%) USD76.84B 24.08 14.94

ETFs Containing SGIOY

Symbol Name SGIOY's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Shionogi & Co Ltd ADR (SGIOY) Stock

Stock Target Advisor's fundamental analysis for Shionogi & Co Ltd ADR's stock is Neutral.

Unfortunately we do not have enough data on SGIOY's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on SGIOY's stock to indicate what its average analyst target is.

SGIOY stock's Price/Earning ratio is 14.96. Our analysis grades SGIOY stock's Price / Earning ratio at F. This means that SGIOY stock's Price/Earning ratio is above 63% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the OTC exchange. Based on this SGIOY may be a overvalued for its sector.

The last closing price of SGIOY's stock was USD 12.74.

The most recent market capitalization for SGIOY is USD 15.48B.

Unfortunately we do not have enough analyst data on SGIOY's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Shionogi & Co Ltd ADR's stock.

As per our most recent records Shionogi & Co Ltd ADR has 5,680 Employees.

Shionogi & Co Ltd ADR's registered address is 1-8, Doshomachi 3-chome, Osaka, Japan, 541-0045. You can get more information about it from Shionogi & Co Ltd ADR's website at https://www.shionogi.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...